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A synthetic cDNA coding for human pancreatic RNase, equipped with a secretion signal sequence, was cloned and stably expressed in Chinese 
hamster ovary cells. The recombinant RNase, secreted into the culture medium, was purified and characterized. It was found to be indistinguishable, 
by structural and catalytic parameters, from the enzyme isolated from human pancreas. Furthermore, the glycosylated forms were separated from 
the non-glycosylated form. Up until now, human RNases have been isolated only in small amounts from autoptic specimens. This has hindered 
the exploitation of a human RNase for the constrnction of i~unotolerated immunotoxins. On the other hand, the availability of an effective system 
for the expression of a human RNase may render feasible the transfer, by protein en~n~~ng, of the interesting pha~acolo~cal actions of 
non-human RNase I1993 Trends Cell Biol. 3, 1061091 to an immunotolemted, human RNase. 
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1. INTRODUCTION 
Human pancreas ~bonu~lease (HP-RNa~), already 
described and partially purified by several investigators 
[l-4], was isolated and characterized by Weickman et 
al. [5], and sequenced by Beintema et al. [6]. Compared 
to bovine pancreatic RNase A [7], the prototype of the 
pancreatic-like superfamily [8] with whom it shares 
about 70% of its amino acid residues, HP-RNase has an 
extension of three residues at the C-terminus, a much 
higher content in basic residues, and is partially (50%) 
glycosylated at Asn34 [6,9]. As an enzyme, HP-RNase 
is less active than RNase A on yeast RNA, but much 
more active on double-stranded RNA [lO,l 11. 
Recently, it has emerged that several ribonucleases 
(the RISBASES, Ribonucleases with Special Biological 
Actions) have non-predictable physiological roles or bio- 
logical actions, in addition to their catalytic activities 
[12]. The interest in these RISBASES derives also from 
the potential appli~tions in biotechnology of some of 
their special actions, such as the antitumor action of 
bovine seminal RNase [ 131 and of amphibian onconase 
[14]. The possibility of using protein engineering to 
transfer such actions, so far detected only in non-human 
RISBASES, to an immunotolerated, human RNase, de- 
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pends on the availability of an effective system for the 
expression of a cDNA coding for a human RNase, Fur- 
thermore, the recently reported const~ction of specifi- 
cally targeted immunotoxins with RNases as toxins 
[l&16] strongly suggests the use of an easily available 
human moiety in such hybrid molecules. 
Here we report the synthesis of a cDNA coding for 
HP-RNase, its stable expression in cultures of Chinese 
hamster ovary cells, and the purification and character- 
ization of the recombinant protein. 
2. MATERIALS AND METHODS 
2.1. Construction of the expression vector 
Bacterial strains, and the general procedures for DNA manipula- 
tions, and bacterial and Eucaryotic cell growth, as well as the proce- 
dure for the construction of the expression vector pMC-E-BS (see 
below) from plasmid pMThGHSV402 [lq, were as previously de- 
scribed [18]. Chinese hamster ovary cells (CHO Kl) were obtained 
from ATCC (Rockville, MD, USA). 
Fig. I illustrates the strategy employed for the construction of the 
expression vector for HP-RNase. A cDNA coding for HP-RNase was 
designed (see Fig. 2) on the basis of the available amino acid sequence 
of HP-RNase [6], with the aid of a computer program [19]. The cDNA, 
equipped with the secretion signal sequence of seminal RNase [20], a 
homologous protein, was constructed from synthetic oligonucleotides 
(Beckman Analytical), using a novel procedure based on the polym- 
erase chain reaction [21]. The outermost 5’- and 3’-end oligonucleo- 
tides contained a BumHI and a &zfi restriction site, respectively. The 
final product of the amplification procedure (491 bp), purified by 
agarose gel electrophoresis, and trimmed with BumHI and San restric- 
tion nucleases, was inserted into the plasmid pMC-E-BS, previously 
freed of the sequence coding for seminal RNase by treatment with the 
same restriction nucleases. The Iigation product was used to transform 
competent JMlOl Escherichia coli cells. Sequence analyses of some 
recombinant clones confirmed that they all harbored the recombinant 
vector, denominated pMC-E-HP, containing the DNA sequence cod- 
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ing for HP-RNase, with the upstream signal sequence of seminal was not studied further. Both fractions Pl and P2 were 
RNase. purified, each with a yield of 1.5 mg/l. 
2.2. Other methods 
Substrates and RNase A (type XII-A) were purchased from Sigma. 
Enzymatic assays were performed on yeast RNA after Kunitz [22], 
and on double-stranded poly(A):poly(U) after Libonati and Floridi 
[23]. The latter method was modified as suggested by S. Sorrentino 
(personal communication). Briefly, to 0.1 mM substrate (from its 
phosphate content), aliquots of enzyme were added to a final volume 
of 1 ml of 0.1 M MOPS buffer at pH 7.5 containing 0.1 M NaCl. 
Absorbance at 260 nm was recorded at 25°C as a function of time. 
One unit of enzymatic activity was defined as the amount of enzyme 
that produced an increase of A,, per min equal to the increase pro- 
duced by the complete transformation of substrate under the assay 
conditions. 
Polyacrylamide gel electrophoresis (SDS-PAGE), detection on gels 
of proteins and of RNase activity, and immunoblots were performed 
as already described [18]. Detection of carbohydrates on gels was 
obtained with the GlycoTrack Kit from Oxford GlycoSystems follow- 
ing the manufacturer’s instructions. Anti-HP-RNase antibodies and 
HP-RNase from human pancreas [5] were kindly provided by Dohn 
G. Glitz, University of California, Los Angeles. 
After SDS-PAGE and Coomassie blue staining, the 
RNases in Pl and P2 were found to run as single bands 
(see Fig. 4, lanes l-3). The molecular size of P2 was that 
expected for HP-RNase (about 15 kDa), whereas PI run 
with a larger size. Activity staining of a parallel gel (Fig. 
4, lanes 4 and 5) confirmed that P2 was a homogeneous 
protein, whereas Pl was found to be heterogeneous. An 
identical result was obtained when a parallel gel was 
blotted onto nitrocellulose and tested with anti-HP- 
RNase antibodies (Fig. 4, lanes 6, 7). When another 
identical gel was blotted onto nitrocellulose and treated 
for carbohydrate detection, only fraction Pl was found 
to be positive and resolved in at least two components 
(see Fig. 4, lanes 8 and 9). 
synthetic oligonucleotides 
3. RESULTS AND DISCUSSION 
3.1. Expression of recombinant HP-RNase 
Stable transfectants were obtained after co-transfec- 
tion of CHO cells with both the pMC-E-HP expression 
vector, containing the cDNA coding for HP-RNase, 
and the pSV2NEO vector inducing resistance to neomy- 
cin [17]. About 100 clones were selected for resistance 
to G418 (a neomycin analog), individually subcultured, 
and induced with 40 mM zinc sulphate in the presence 
of 0.5% fetal calf serum. The medium of each culture 
was assayed for activity on double-stranded 
poly(A):poly(U). The clone with the highest secretion 
level was propagated and found to be stable through 10 
population doublings in the absence of the selecting 
agent G418. 
BarnHI 
I 
I PCR amplification, Barn HI and Sal I digestion 
preHP cDNA 
SalI 
I_ 
479 bp 
SV40 Enhancer 
3.2. Purification and characterization of recombinant 
HP-RNase 
Conditioned medium (1 liter) from CHO cells trans- 
fected with plasmid pMC-E-HP, and induced as de- 
scribed above, was concentrated lo-fold on an Amicon 
concentrator equipped with a YM3 membrane. The 
concentrated material was dialyzed against 50 mM Tris- 
Cl, pH 7, clarified by centrifugation, and loaded on a 
column (1.5 x 6 cm) of carboxymethyl-cellulose (CM- 
32, Whatman) equilibrated in the same buffer. The col- 
umn was washed with about 200 ml of the equilibration 
buffer and eluted with 100 ml of a linear NaCl gradient 
(o-0.4 M) in the same buffer. As shown in Fig. 3, RNase 
activity distributed among the fraction unadsorbed by 
the cation exchanger, and two sharp activity peaks, Pl 
and P2, eluted at about 0.16 M and 0.22 M NaCl, 
respectively. The Pl and P2 active fractions were de- 
salted by dialysis against water, and analyzed. The 
RNase activity unadsorbed by the ion exchange column 
BarnHI SdI 
Fig. 1. Strategy for the construction of the plasmid pMC-E-HP for the 
expression of an HP-RNase cDNA equipped with a signal sequence. 
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10 20 30 40 50 60 
I I I I I 
GAGGTCAT~CTCTGAAGTCTCTAGTCGTGTTGCCACTGCTGGTCCT 
MALKSLVVLPLLVL 
Barn’ HI ( - i6 ) 
70 00 90 100 110 120 
I I i I I I 
~TG~GCTG~GGTGCG~TC~GC~TCCCT~G~~T~A~GCT~~ 
VLLLVRVQPSLGKESRAKKF 
L f+l) 
130 140 150 160 170 180 
I I I I I I 
CCAGCGTti9A~TA~A~CTGACTCGAOCCCCGTCTTCTTCTTCTACGTACTGC~CCT 
QRQHMDSDSSPSSSSTYCNL 
190 200 210 220 230 240 
I I I I I I 
GATGATGTGCTGCCGTAACATGACCC~GGTC~~GC~CCGGTG~~~~CGTTCA 
MMCCRNMTQGRCKPVNTFVH 
250 260 270 280 290 300 
i I I I I I 
TGAACCGCTTGTAGACGTTCAGAACGTTTGCTTCCAAGAGAAGGTTACCTGC!AA?&ATGG 
EPLVDVQNVCFQEKVTCKNG 
310 320 330 340 350 360 
I I I I I I 
CCAGGGTAACTGCTACAAATCTAACTCT~TTCTATGCATATCACTGACTGCCGTCTTACT~ 
QGNCYKSNSSMHITDCRLTN 
370 380 390 400 410 420 
I I I I I I 
CGGATrJCCGTTACCCCAACTGC~TTAC~GTACTTCTC~~GG~CGTCATATCATCGT 
GSRYPNCAYRTSPKERHISV 
430 440 450 460 
I 
470 
I 
400 
I I I I 
TGCATGCGAAGGCTCTCCGTACGTTCCGGTTCATTTCGCCTCTTG 
ACEGSPYVPVHFDASVEDS- 
490 
I 
TG 
Sal I 
Fig. 2. Sequence of a synthetic DNA coding for HP-RNase (bases 98-480) with an upstream sequence coding for a secretion signal peptide (bases 
20-97). Restriction sites for BarnHI (at the Y-end) and SalI (at the 3’-end) are also shown. 
These data indicate that both Pl and P2 fractions can 
be identified as distinct molecular species of HP-RNase, 
as they both react with anti-HP-RNase antibodies. 
They also show that Pl is a mixture of glycosylated 
forms of HP-RNase, and that P2 does not contain any 
carbohydrates. 
It has been reported [6] that purified HP-RNase con- 
sists of two species, one of them glycosylated, in a ratio 
of about 1:l; furthermore, in that report the authors 
surmised that the component with the higher mobility 
separated by SDS-PAGE in these preparations of HP- 
RNase, was probably the non-glycosylated form of the 
protein, while the slow-moving components were glyco- 
sylated forms. Clearly, the chromatographic system em- 
ployed here separated the non-~ycosylated form of the 
enzyme from a composite of glycosylated species. 
The amino acid composition of the non-glycosylated 
form (P2 fraction) was found (not shown) to be identi- 
cal, within experimental error, with that derived from 
the sequence of HP-RNase isolated from human pan- 
creas [6]. N-terminal sequence analyses of fractions Pl 
and P2 of rHP-RNase revealed that for both fractions 
the sequence of residues 1-19 was identical with that of 
the protein isolated from human pancreas [6j (data not 
shown). This indicated a correct processing of the signal 
sequence. 
The two components of rHP-RNase as isolated were 
also characterized in their main enzymic properties. As 
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Fig. 3. Carboxymethyl-cellulose chromatography of culture medium 
of CHO cells transfected with the expression vector pMC-E-HP har- 
boring HP-RNase cDNA. The tracing of absorbance at 275 nm (---) 
and RNase activity measured on poly(A):poly(U) as a substrate (m-m) 
are shown. 
summarized in Table I, they were found to be virtually 
undistinguishable one from the other, and both from 
the enzyme isolated from human pancreas, in their ac- 
tivities on yeast RNA and on a double-stranded 
poly(A):poly(U) substrate. As previously reported for 
the enzyme purified from human pancreas [l 11, rHP- 
RNase was found to be much more active than RNase 
A on double-stranded RNA and less active on single- 
stranded RNA. 
3.3. Concluding remarks 
HP-RNase was stably produced by CHO cells trans- 
fected with a plasmid containing a DNA sequence cod- 
ing for the protein. Both the non-glycosylated and the 
glycosylated forms of the protein were obtained and 
separated. 
It should be noted that, to our knowledge, this is the 
first human RNase, with the exception of angiogenin, 
an RNase with low catalytic activity on standard RNase 
Table I 
Comparison among the activities of HP-RNase, rHP-RNase, and 
RNase A on single- and double-stranded substrates 
Substrate 
poly(A):poly(U) yeast RNA 
Specific activity 
(U/mg) 
HP-RNase 520 33.8 
rHP-RNase Pl 490 26.1 
rHP-RNase P2 502 28.2 
RNase A 1.8 104.1 
HP-RNase isolated from human pancreas, fractions Pl (glycosylated) 
and P2 (non-glycosylated) of recombinant rHP-RNase, and RNase A, 
were tested on double-stranded poly(A):poly(U) and on yeast RNA 
as described in Section 2. 
kDa 
46.0 - 
30.0 - 
13.7 - 
123 45 67 89 
November 1993 
Fig. 4. SDS-gel electrophoresis of fractions Pl and P2 of recombinant 
HP-RNase. Lanes 1,4,6, and 8: fraction Pl of rHP-RNase. Lanes 2, 
5, 7, and 9: fraction P2 of rHP-RNase. Lane 3: a mixture of fraction 
Pl and P2 of rHP-RNase. Lanes l-3: staining with Coomassie blue. 
Lanes 4, 5: RNase zymogram. Lanes 6, 7: immunoblot reated with 
anti-HP-RNase antibodies. Lanes 8, 9: blot treated for carbohydrate 
detection. 
substrates [24], to be cloned and expressed at satisfac- 
tory expression levels (5 mg/l of culture medium). 
Recently, the expression in Saccharomyces cerevisiae 
of a synthetic gene for HP-RNase has been reported 
[25]. The expression product, assayed in the culture me- 
dium, was found to be a mixture of glycosylated forms, 
amounting to less than 1 mg/l of culture medium. 
The amount of purified rHP-RNase which can be 
obtained by the one-step purification procedure re- 
ported here from one liter of culture medium is compa- 
rable to what can be isolated after a lengthy, several- 
step procedure, from more than 10 human pancreases. 
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